Published in Lancet on June 05, 1999
Screening for breast cancer. JAMA (2005) 4.56
Evidence for risk of bias in cluster randomised trials: review of recent trials published in three general medical journals. BMJ (2003) 4.18
Aggregate cost of mammography screening in the United States: comparison of current practice and advocated guidelines. Ann Intern Med (2014) 3.78
Contamination in trials: is cluster randomisation the answer? BMJ (2001) 3.61
The benefits and harms of breast cancer screening: an independent review. Br J Cancer (2013) 3.43
Breast cancer mortality in Copenhagen after introduction of mammography screening: cohort study. BMJ (2005) 3.21
Overdiagnosis and overtreatment of breast cancer: overdiagnosis in randomised controlled trials of breast cancer screening. Breast Cancer Res (2005) 2.81
An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat (2007) 2.65
Racial differences in knowledge, attitudes, and cancer screening practices among a triracial rural population. Cancer (2004) 1.97
Breast screening in women aged 40-49 years: what next? Lancet (1999) 1.82
Preventive health care, 2001 update: screening mammography among women aged 40-49 years at average risk of breast cancer. CMAJ (2001) 1.74
Obesity and mammography: a systematic review and meta-analysis. J Gen Intern Med (2009) 1.57
Randomised controlled trials in primary care: scope and application. Br J Gen Pract (2002) 1.54
Decision making and counseling around mammography screening for women aged 80 or older. J Gen Intern Med (2006) 1.45
Predictors of mammography use among Canadian women aged 50-69: findings from the 1996/97 National Population Health Survey. CMAJ (2001) 1.43
The first national public breast cancer screening program in Saudi Arabia. Ann Saudi Med (2010) 1.39
Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study. BMC Cancer (2006) 1.16
Comparison of 1- and 2-year screening intervals for women undergoing screening mammography. Br J Cancer (2005) 1.16
Will screening mammography in the East do more harm than good? Am J Public Health (2002) 1.08
Pathology characteristics that optimize outcome prediction of a breast screening trial. Br J Cancer (2000) 1.06
Surgery triggers outgrowth of latent distant disease in breast cancer: an inconvenient truth? Cancers (Basel) (2010) 1.04
Application of magnetic resonance imaging to early detection of breast cancer. Breast Cancer Res (2001) 1.04
Racial/ethnic differences in early detection of breast cancer: a study of 250,985 cases from the California Cancer Registry. J Womens Health (Larchmt) (2010) 1.01
A simulation model investigating the impact of tumor volume doubling time and mammographic tumor detectability on screening outcomes in women aged 40-49 years. J Natl Cancer Inst (2010) 0.96
Current and future technologies for breast cancer imaging. Breast Cancer Res (2001) 0.92
Impact of mammographic screening on ethnic and socioeconomic inequities in breast cancer stage at diagnosis and survival in New Zealand: a cohort study. BMC Public Health (2015) 0.90
Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women. Breast Cancer Res (2012) 0.90
The menopause and its treatment in perspective. Postgrad Med J (2001) 0.86
The influence of breast self-examination on subsequent mammography participation. Am J Public Health (2005) 0.82
Chiral porphyrazine near-IR optical imaging agent exhibiting preferential tumor accumulation. Proc Natl Acad Sci U S A (2009) 0.82
Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis. Ont Health Technol Assess Ser (2007) 0.78
Should women under 50 be screened for breast cancer? Br J Cancer (2004) 0.78
A national study of out-of-pocket expenditures for mammography screening. J Womens Health (Larchmt) (2011) 0.78
Design of cancer screening trials/randomized trials for evaluation of cancer screening. World J Surg (2006) 0.78
Meta-analysis of breast cancer mortality benefit and overdiagnosis adjusted for adherence: improving information on the effects of attending screening mammography. Br J Cancer (2016) 0.77
At what age should screening mammography be recommended for Asian women? Cancer Med (2015) 0.77
Updated results of the Gothenburg Trial of Mammographic Screening. Cancer (2016) 0.77
99mTc-thymine scintigraphy may be a promising method in the diagnosis of breast cancer. Clinics (Sao Paulo) (2013) 0.77
Prognosis of screen-detected breast cancers: results of a population based study. BMC Cancer (2006) 0.76
A meta-analysis of mammographic screening with and without clinical breast examination. Cancer Sci (2015) 0.75
Bayesian spatiotemporal modelling for identifying unusual and unstable trends in mammography utilisation. BMJ Open (2016) 0.75
Assessment of the clinical utility of the Gail model in estimating the risk of breast cancer in women from the Indian population. Ecancermedicalscience (2013) 0.75
Breast screening in women aged 40-49 years. Lancet (1999) 0.75
Screening for breast cancer with mammography. Lancet (2002) 0.75
Physicians' attitudes and behaviour toward screening mammography in women 40 to 49 years of age. Can Fam Physician (2012) 0.75
Automatic Estimation of Volumetric Breast Density Using Artificial Neural Network-Based Calibration of Full-Field Digital Mammography: Feasibility on Japanese Women With and Without Breast Cancer. J Digit Imaging (2016) 0.75
Breast screening in women aged 40-49 years. Lancet (1999) 0.75
Breast screening in women aged 40-49 years. Lancet (1999) 0.75
Is there excess mortality in women screened with mammography: a meta-analysis of non-breast cancer mortality. Trials (2013) 0.75
Locoregional treatment for breast cancer. BMJ (2003) 0.75
Clarifying the debate on population-based screening for breast cancer with mammography: A systematic review of randomized controlled trials on mammography with Bayesian meta-analysis and causal model. Medicine (Baltimore) (2017) 0.75
An audit of screening for familial breast cancer before 50 years in the South Thames Region - have we got it right? Fam Cancer (2004) 0.75
Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell (1998) 19.05
Zebrafish informatics and the ZFIN database. Methods Cell Biol (1999) 16.45
Explaining variation in general practitioner referrals to hospital. Fam Pract (1987) 10.27
Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev (1998) 8.51
Prevalence of antibodies to human immunodeficiency virus, gonorrhoea rates, and changed sexual behaviour in homosexual men in London. Lancet (1987) 7.71
Altered immune responses in mice lacking inducible nitric oxide synthase. Nature (1995) 6.20
Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet (1990) 6.17
Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst (1998) 6.06
Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet (2000) 5.93
National Health Service breast screening programme results for 1991-2. BMJ (1993) 5.79
Assessing completeness of cancer registration in the north-western region of England by a method of independent comparison. Br J Cancer (1982) 4.90
Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol (1991) 4.67
Application of genetic markers to the identification of recrudescent Plasmodium falciparum infections on the northwestern border of Thailand. Am J Trop Med Hyg (1999) 4.60
Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst (1981) 4.60
Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn (2010) 4.48
Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression. Proc Natl Acad Sci U S A (1994) 4.44
Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet (1998) 4.44
The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci (1999) 4.35
Day care after operations for hernia or varicose veins: a controlled trial. Br J Surg (1978) 4.30
Smoking habits of oral contraceptive users. Lancet (1969) 4.20
Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev Biol (1999) 4.00
Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). Circulation (1998) 3.99
Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med (2001) 3.98
Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet (1992) 3.94
Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science (1999) 3.85
Familial Hypercholesterolaemia Regression Study: a randomised trial of low-density-lipoprotein apheresis. Lancet (1995) 3.74
Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and scanning electron microscopy. Gut (1985) 3.48
Identification of the NH2-terminal blocking group of calcineurin B as myristic acid. FEBS Lett (1982) 3.42
The MoCA: well-suited screen for cognitive impairment in Parkinson disease. Neurology (2010) 3.36
Phylogeny of Wolbachia in filarial nematodes. Proc Biol Sci (1998) 3.35
Twelve-year comparison of a Bjork-Shiley mechanical heart valve with porcine bioprostheses. N Engl J Med (1991) 3.31
Fine needle aspiration cytology, in relationships to clinical examination and mammography in the diagnosis of a solid breast mass. Br J Surg (1984) 3.30
Anticoagulation for three versus six months in patients with deep vein thrombosis or pulmonary embolism, or both: randomised trial. BMJ (2007) 3.26
Management of acute stroke in the elderly: preliminary results of a controlled trial. Br Med J (1980) 3.15
Influence of blood lead on the ability and attainment of children in Edinburgh. Lancet (1987) 3.08
Acceptors and rejectors of an invitation to undergo breast screening compared with those who referred themselves. J Epidemiol Community Health (1980) 2.95
Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet (1996) 2.78
Caesarean scar pregnancy. BJOG (2007) 2.77
Predicting successful vaginal birth after Cesarean section using a model based on Cesarean scar features examined by transvaginal sonography. Ultrasound Obstet Gynecol (2013) 2.73
Uptake and acceptability of antenatal HIV testing: randomised controlled trial of different methods of offering the test. BMJ (1998) 2.73
Does it matter where you live? Treatment variation for breast cancer in Yorkshire. The Yorkshire Breast Cancer Group. Br J Cancer (1995) 2.71
Audit commission tackles anaesthetic services. BMJ (1998) 2.70
Contrast extravasation on CT predicts mortality in primary intracerebral hemorrhage. AJNR Am J Neuroradiol (2007) 2.69
Delay in breast cancer and the nature of presenting symptoms. Lancet (1981) 2.67
Management of acute stroke in the elderly: follow-up of a controlled trial. Br Med J (1980) 2.67
The efficacy of double reading mammograms in breast screening. Clin Radiol (1994) 2.60
British Thoracic Society Sarcoidosis study: effects of long term corticosteroid treatment. Thorax (1996) 2.58
A radiation hybrid map of the rat genome containing 5,255 markers. Nat Genet (1999) 2.54
A phylogenetic analysis of filarial nematodes: comparison with the phylogeny of Wolbachia endosymbionts. Parasitology (2001) 2.53
Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur Respir J (2003) 2.51
The effect of adjunctive fresh frozen plasma administration on coagulation parameters and survival in a canine model of antivenom-treated brown snake envenoming. Anaesth Intensive Care (2005) 2.49
Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg (2001) 2.47
Oral contraceptives and venous thromboembolism: findings in a large prospective study. Br Med J (Clin Res Ed) (1986) 2.47
The prevalence of diabetic impotence. Diabetologia (1980) 2.47
A national health service and the public health. Public Health (1988) 2.46
On-site HIV testing in resource-poor settings: is one rapid test enough? AIDS (1997) 2.39
Randomised controlled trial of self management leaflets and booklets for minor illness provided by post. BMJ (2001) 2.35
Microchimerism of maternal origin persists into adult life. J Clin Invest (1999) 2.35
Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol (2002) 2.34
Antimicrobial resistance: Antibiotics and consultant oral microbiologist posts. Br Dent J (2016) 2.32
Oestrogen receptors and breast cancer: current status. Br J Surg (1980) 2.31
Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs. Thorax (2000) 2.31
Management of the axilla in operable breast cancer treated by breast conservation: a randomized clinical trial. Edinburgh Breast Unit. Br J Surg (2000) 2.30
Recommendations for conducting the in vivo alkaline Comet assay. 4th International Comet Assay Workshop. Mutagenesis (2003) 2.29
Clinical pharmacology clinics in general practice. Br Med J (1977) 2.28
Acute encephalopathy coincident with seroconversion for anti-HTLV-III. Lancet (1985) 2.26
Qualms about QALYs. Lancet (1987) 2.26
Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol (2001) 2.24
A numerical prognostic index for clinical use in identification of poor-risk patients with Hodgkin's disease at diagnosis. The Scotland and Newcastle Lymphoma Group (SNLG) Therapy Working Party. Leuk Lymphoma (1992) 2.23
Association between mortality among women and socioeconomic factors in general practices in Edinburgh: an application of small area statistics. Br Med J (Clin Res Ed) (1987) 2.22
Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr Biol (1998) 2.20
Reversible posterior leukoencephalopathy syndrome: a misnomer reviewed. Intern Med J (2005) 2.16
Childhood-onset schizophrenia. Progressive ventricular change during adolescence. Arch Gen Psychiatry (1997) 2.15
A comparison of dermatologists', surgeons' and general practitioners' surgical management of cutaneous melanoma. Br J Dermatol (2004) 2.14
Isolation of stable mouse cell lines that express cell surface and secreted forms of the vesicular stomatitis virus glycoprotein. J Cell Biol (1983) 2.14
Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening. J Clin Oncol (1999) 2.13
A quantitative assessment of residual protein levels on dental instruments reprocessed by manual, ultrasonic and automated cleaning methods. Br Dent J (2011) 2.13
Non-invasive markers of bone turnover and plasma cytokines differ in osteoporotic patients with multiple myeloma and monoclonal gammopathies of undetermined significance. Intern Med J (2001) 2.12
Improved endothelial function with metformin in type 2 diabetes mellitus. J Am Coll Cardiol (2001) 2.10
Human T-lymphotropic virus type III (HTLV-III) infection in seronegative haemophiliacs after transfusion of factor VIII. Lancet (1985) 2.08
Cross infection control measures and the treatment of patients at risk of Creutzfeldt Jakob disease in UK general dental practice. Br Dent J (2001) 2.08
Outcome of elective prostatectomy. BMJ (1989) 2.08
The endocrinology of the menopausal transition: a cross-sectional study of a population-based sample. J Clin Endocrinol Metab (1995) 2.07
Maintenance of the pluripotential phenotype of embryonic stem cells through direct activation of gp130 signalling pathways. Mech Dev (1994) 2.07
Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide. Am J Physiol (1996) 2.06
Clinical and ultrasound prediction of macrosomia in diabetic pregnancy. Br J Obstet Gynaecol (1996) 2.05
Sequence of the preprotoxin dsRNA gene of type I killer yeast: multiple processing events produce a two-component toxin. Cell (1984) 2.03
A verandah-trap hut for studying the house-frequenting habits of mosquitoes and for assessing insecticides. 3. The effect of DDT on behavior and mortality. Bull Entomol Res (1969) 2.03
The management of acute abdominal pain in children. J Paediatr Child Health (1996) 2.02
Endothelin receptor blockade improves endothelial function in human internal mammary arteries. Cardiovasc Res (2001) 2.02
Does the presence of a cesarean section scar influence the site of placental implantation and subsequent migration in future pregnancies: a prospective case-control study. Ultrasound Obstet Gynecol (2012) 1.98
Infiltrating lobular carcinoma of the breast. Histopathology (1982) 1.98
Significance of aromatase activity in human breast cancer. Cancer Res (1982) 1.97
Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin Cancer Res (1996) 1.95